Phase I/II Study of Chemoradiotherapy with Paclitaxel for Elderly Stage IB-III Esophageal Cancer
- Conditions
- Esophageal Cancer
- Registration Number
- JPRN-UMIN000020397
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 74
Not provided
1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2) Infectious disease with systemic therapy indicated. 3) Severe psychiatric disease. 4) Continuous systemic steroid therapy. 5) Poorly controlled diabetes mellitus. 6) Severe pulmonary fibrosis or emphysema. 7) Unstable angina pectoris, or history of myocardial infarction within three months. 8) Other conditions not suitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method